Primary Immunodeficiencies with Elevated IgE

REFERENCES

• Casanova JL, Abel L, Quintana-Murci L. Immunology taught by human genetics. Cold Spring Harb Symp Quant Biol 2013;78:157–172.
   PubMedGoogle Scholar
• Ochs HD, Smith CIE, Puck JM. Primary immunodeficiencies: a molecular and genetic approach, 2nd ed. New York, NY: Oxford University Press; 2007.
   Google Scholar
• Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007;357:1608–1619.
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007;448:1058–1062.
   PubMed Web of Science ®Google Scholar
• Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008;452:773–776.
   PubMed Web of Science ®Google Scholar
• Engelhardt KR, McGhee S, Winkler S, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 2009;124:1289–1302.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 2009;361:2046–2055.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yu X, Ichikawa M, et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol 2014;133:1400–1409.
   PubMed Web of Science ®Google Scholar
• Sassi A, Lazaroski S, Wu G, et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol 2014;133:1410–1419.
   PubMed Web of Science ®Google Scholar
• Davis SD, Schaller J, Wedgwood RJ. Job's Syndrome. Recurrent, “cold,” staphylococcal abscesses. Lancet 1966;1:1013–1015.
   PubMed Web of Science ®Google Scholar
• Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 1972;49:59–70.
   PubMed Web of Science ®Google Scholar
• Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci 2012;1250:25–32.
   PubMed Web of Science ®Google Scholar
• Kindle G, Gathmann B, Grimbacher B. The use of databases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2014;14(6):501–508.
   PubMed Web of Science ®Google Scholar
• Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 1972;49:59–70.
   PubMed Web of Science ®Google Scholar
• Siegel AM, Heimall J, Freeman AF, et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 2011;35: 806–818.
   PubMed Web of Science ®Google Scholar
• Smithwick EM, Finelt M, Pahwa S, et al. Cranial synostosis in Job's syndrome. Lancet 1978;1:826.
   PubMed Web of Science ®Google Scholar
• O'Connell AC, Puck JM, Grimbacher B, et al. Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:177–185.
   PubMed Web of Science ®Google Scholar
• Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections –an autosomal dominant multisystem disorder. N Engl J Med 1999;340:692–702.
   PubMed Web of Science ®Google Scholar
• Freeman AF, Avila EM, Shaw PA, et al. Coronary artery abnormalities in hyper-IgE syndrome. J Clin Immunol 2011;31:338–345.
   PubMed Web of Science ®Google Scholar
• Freeman AF, Collura-Burke CJ, Patronas NJ, et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics 2007;119:e1121–e1125.
   PubMed Web of Science ®Google Scholar
• Leonard GD, Posadas E, Herrmann PC, et al. Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma 2004;45:2521–2525.
   PubMed Web of Science ®Google Scholar
• Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007;357:1608–1619.
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Saito M, Tsuchiya S, et al.et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007;448:1058–1062.
   PubMed Web of Science ®Google Scholar
• Renner ED, Rylaarsdam S, Anover-Sombke S, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol 2008;122:181–187.
   PubMed Web of Science ®Google Scholar
• Mogensen TH, Jakobsen MA, Larsen CS. Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome. Scand J Infect Dis 2013;45:235–238.
   PubMed Web of Science ®Google Scholar
• Woellner C, Gertz EM, Schaffer AA, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol 2010;125:424–432.
   PubMed Web of Science ®Google Scholar
• Tamassia N, Castellucci M, Rossato M, et al. Uncovering an IL-10-dependent NF-kappaB recruitment to the IL-1ra promoter that is impaired in STAT3 functionally defective patients. FASEB J 2010;24:1365–1375.
   PubMed Web of Science ®Google Scholar
• O'Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012;36:542–550.
   PubMed Web of Science ®Google Scholar
• Takeda K, Noguchi K, Shi W, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997;94:3801–3804.
   PubMed Web of Science ®Google Scholar
• Wang WB, Levy DE, Lee CK. STAT3 negatively regulates type I IFN-mediated antiviral response. J Immunol 2011;187:2578–2585.
   PubMed Web of Science ®Google Scholar
• Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008;452:773–776.
   PubMed Web of Science ®Google Scholar
• Puel A, Cypowyj S, Marodi L, et al. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 2012;12:616–622.
   PubMed Web of Science ®Google Scholar
• Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999;162:2347–2352.
   PubMed Web of Science ®Google Scholar
• Hill HR, Ochs HD, Quie PG, et al. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent “cold” staphylococcal abscesses. Lancet 1974;2:617–619.
   PubMed Web of Science ®Google Scholar
• Buckley RH, Becker WG. Abnormalities in the regulation of human IgE synthesis. Immunol Rev 1978;41:288–314.
   PubMed Web of Science ®Google Scholar
• Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151–1160.
   PubMed Web of Science ®Google Scholar
• Conti HR, Baker O, Freeman AF, et al. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol 2011;4:448–455.
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Saito M, Nagasawa M, et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 2009;206:1291–1301.
   PubMed Web of Science ®Google Scholar
• Speckmann C, Enders A, Woellner C, et al. Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol 2008;129:448–454.
   PubMed Web of Science ®Google Scholar
• Avery DT, Deenick EK, Ma CS, et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2010;207:155–171.
   PubMed Web of Science ®Google Scholar
• Ozaki K, Spolski R, Feng CG, et al. A critical role for IL-21 in regulating immunoglobulin production. Science 2002;298:1630–1634.
   PubMed Web of Science ®Google Scholar
• Avery DT, Ma CS, Bryant VL, et al. STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood 2008;112:1784–1793.
   PubMed Web of Science ®Google Scholar
• Kotlarz D, Zietara N, Uzel G, et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med 2013;210:433–443.
   PubMed Web of Science ®Google Scholar
• Wesemann DR, Magee JM, Boboila C, et al. Immature B cells preferentially switch to IgE with increased direct SMU to Sepsilon recombination. J Exp Med 2011;208:2733–2746.
   PubMed Web of Science ®Google Scholar
• Saito M, Nagasawa M, Takada H, et al. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med 2011;208:235–249.
   PubMed Web of Science ®Google Scholar
• Panopoulos AD, Zhang L, Snow JW, et al. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 2006;108:3682–3690.
   PubMed Web of Science ®Google Scholar
• Nieminen P, Morgan NV, Fenwick AL, et al. Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet 2011;89:67–81.
   PubMed Web of Science ®Google Scholar
• Kida H, Mucenski ML, Thitoff AR, et al. GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol 2008;172:1542–1554.
   PubMed Web of Science ®Google Scholar
• Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006;355:788–798.
   PubMed Web of Science ®Google Scholar
• Kovacic JC, Gupta R, Lee AC, et al. Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J Clin Invest 2010;120:303–314.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Welte T, Troiano N, et al. Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice. Biochem Biophys Res Commun 2005;328:800–807.
   PubMed Web of Science ®Google Scholar
• Okada S, Nakamura M, Katoh H, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006;12:829–834.
   PubMed Web of Science ®Google Scholar
• Debnath B, Xu S, Neamati N. Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein. J Med Chem 2012;55:6645–6668.
   PubMed Web of Science ®Google Scholar
• Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity 2012;36:515–528.
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006;25:745–755.
   PubMed Web of Science ®Google Scholar
• Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, et al. A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome. J Pediatr 2012;160:1055–1057.
   PubMed Web of Science ®Google Scholar
• Renner ED, Puck JM, Holland SM, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 2004;144:93–99.
   PubMed Web of Science ®Google Scholar
• Su HC, Jing H, Zhang Q. DOCK8 deficiency. Ann N Y Acad Sci 2011;1246:26–33.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Davis JC, Dove CG, Su HC. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis Markers 2010;29:131–139.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Su HC. Hyperimmunoglobulin E syndromes in pediatrics. Curr Opin Pediatr 2011;23:653–658.
   PubMed Web of Science ®Google Scholar
• Jabara HH, McDonald DR, Janssen E, et al. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol 2012;13:612–620.
   PubMed Web of Science ®Google Scholar
• Al KS, Keles S, Garcia-Lloret M, et al. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper-IgE syndrome. J Allergy Clin Immunol 2009;124:342–348.
   PubMed Web of Science ®Google Scholar
• Simon AR, Vikis HG, Stewart S, et al. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 2000;290:144–147.
   PubMed Web of Science ®Google Scholar
• Rael EL, Marshall RT, McClain JJ. The hyper-IgE syndromes: lessons in nature, from bench to bedside. World Allergy Organ J 2012;5:79–87.
   PubMedGoogle Scholar
• Dasouki M, Okonkwo KC, Ray A, et al. Deficient T cell receptor excision circles (TRECs) in autosomal recessive hyper-IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening. Clin Immunol 2011;141:128–132.
   PubMed Web of Science ®Google Scholar
• Harada Y, Tanaka Y, Terasawa M, et al. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood 2012;119:4451–4461.
   PubMed Web of Science ®Google Scholar
• Su HC, Jing H, Zhang Q. DOCK8 deficiency. Ann N Y Acad Sci 2011;1246:26–33.
   PubMed Web of Science ®Google Scholar
• Jabara HH, McDonald DR, Janssen E, et al. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol 2012;13:612–620.
   PubMed Web of Science ®Google Scholar
• Yong PF, Freeman AF, Engelhardt KR, et al. An update on the hyper-IgE syndromes. Arthritis Res Ther 2012;14:228.
   PubMed Web of Science ®Google Scholar
• Randall KL, Lambe T, Goodnow CC, Cornall RJ. The essential role of DOCK8 in humoral immunity. Dis Markers 2010;29:141–150.
   PubMed Web of Science ®Google Scholar
• Lambe T, Crawford G, Johnson AL, et al. DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol 2011;41:3423–3435.
   PubMed Web of Science ®Google Scholar
• Alsum Z, Hawwari A, Alsmadi O, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. J Clin Immunol 2013;33:55–67.
   PubMed Web of Science ®Google Scholar
• Watford WT, O'Shea JJ. Human tyk2 kinase deficiency: another primary immunodeficiency syndrome. Immunity 2006;25:695–697.
   PubMed Web of Science ®Google Scholar
• Shaw MH, Boyartchuk V, Wong S, et al. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc Natl Acad Sci USA 2003;100:11594–11599.
   PubMed Web of Science ®Google Scholar
• Wolfe LA, Krasnewich D. Congenital disorders of glycosylation and intellectual disability. Dev Disabil Res Rev 2013;17:211–225.
   PubMed Web of Science ®Google Scholar
• Greig KT, Antonchuk J, Metcalf D, et al. Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development. Mol Cell Biol 2007;27:5849–5859.
   PubMed Web of Science ®Google Scholar
• Ozcan E, Notarangelo LD, Geha RS. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol 2008;122:1054–1062.
   PubMed Web of Science ®Google Scholar
• Antoniades K, Hatzistilianou M, Pitsavas G, et al. Co-existence of Dubowitz and hyper-IgE syndromes: a case report. Eur J Pediatr 1996;155:390–392.
   PubMed Web of Science ®Google Scholar
• Boeck A, Gfatter R, Braun F, Fritz B. Pentasomy X and hyper IgE syndrome: co-existence of two distinct genetic disorders. Eur J Pediatr 1999;158:723–726.
   PubMed Web of Science ®Google Scholar
• Boeck A, Kosan C, Ciznar P, Kunz J. Saethre-Chotzen syndrome and hyper IgE syndrome in a patient with a novel 11 bp deletion of the TWIST gene. Am J Med Genet 2001;104:53–56.
   PubMed Web of Science ®Google Scholar
• Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th ed. London: Churchill Livingstone; 2010.
   Google Scholar
• Ghoreschi K, Laurence A, O'Shea JJ. Janus kinases in immune cell signaling. Immunol Rev 2009;228:273–287.
   PubMed Web of Science ®Google Scholar
• Goussetis E, Peristeri I, Kitra V, et al. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol 2010;126:392–394.
   PubMed Web of Science ®Google Scholar
• Gatz SA, Benninghoff U, Schutz C, et al. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant 2011;46:552–556.
   PubMed Web of Science ®Google Scholar
• Barlogis V, Galambrun C, Chambost H, et al. Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency. J Allergy Clin Immunol 2011;128:420–422.
   PubMed Web of Science ®Google Scholar